Eslopam 20mg Tablet contains Escitalopram Oxalate, a selective serotonin reuptake inhibitor (SSRI) indicated for the treatment of major depressive disorder (MDD) and generalized anxiety disorder (GAD). By selectively inhibiting the reuptake of serotonin in the central nervous system, Eslopam enhances serotonergic activity, thereby improving mood, anxiety symptoms, and overall emotional balance. The recommended dosage is typically 10-20 mg once daily, adjusted according to clinical response and tolerability. Eslopam is generally well tolerated; however, patients may experience side effects such as nausea, headache, insomnia, dry mouth, or dizziness. It is contraindicated in individuals with known hypersensitivity to escitalopram or citalopram and should be used cautiously in patients with a history of bipolar disorder, seizures, or hepatic impairment. Abrupt discontinuation may lead to withdrawal symptoms; hence, gradual dose tapering is advised. Eslopam may interact with monoamine oxidase inhibitors (MAOIs), other serotonergic agents, and drugs affecting cytochrome P450 enzymes, necessitating careful monitoring. Regular assessment of therapeutic response and adverse effects is essential during treatment. Eslopam 20mg Tablet should be prescribed and administered under medical supervision, with consideration of individual patient factors to optimize efficacy and safety.